For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Dna Twopointo Inc.

Calculating rank

USPTO Granted Patents = 37

EPO Patents = 5

Trademarks = 8

Forward Citations = 196

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Jeremy S Minshull (32 out of 126 patents)

Maggie Lee (17 out of 21 patents)

Sridhar Govindarajan (14 out of 39 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

6. Mark D Welch (7 out of 40 patents)

7. Elias Theodorou (5 out of 5 patents)

8. Sridhar Govindrajan (3 out of 10 patents)

9. Kate Caves (3 out of 9 patents)

10. Varsha Sitaraman (2 out of 2 patents)

11. Ferenc Boldog (2 out of 2 patents)

12. Benedikt K Vollrath (1 out of 27 patents)

13. Mark Cobbold (1 out of 16 patents)

14. Wenhua Lu (1 out of 9 patents)

15. Richard A Gross (1 out of 36 patents)

Core Competencies:

Eukaryotic Cells

Transposase

Gene Expression

Nucleic Acids

CAR-T Cells

Micro-RNA

Synthetic Nucleic Acids

Biopolymer Engineering

DNA Cloning

Fluorescent Proteins

Transposons

Expression Systems

37 patents: Sort by Forward Citations

1. 12742171 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2026-09-22),

2. 12612646 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2026-04-28),

3. 12590319 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2026-03-31),

4. 12473335 - ORTHOGONAL IL-21 RECEPTOR/CYTOKINE SYSTEMS (2025-11-18),

5. 12419913 - Modification of CAR-T cells (2025-09-23),

6. 12404504 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis (2025-09-02),

7. 12351813 - Tetracycline-inducible expression system (2025-07-08),

8. 12351800 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2025-07-08),

9. 12122995 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-10-22),

10. 12054702 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-08-06),

11. 11845936 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2023-12-19),

12. 11713468 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2023-08-01),

13. 11566262 - Tetracycline-inducible expression systems (2023-01-31),

14. 11401521 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2022-08-02),

15. 11396662 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2022-07-26),

Company Overview

Dna Twopointo Inc. is a biotechnology company based in Newark, California, specializing in advanced DNA sequencing technologies. The organization focuses on developing innovative solutions that enhance genetic analysis and facilitate research in genomics. By leveraging cutting-edge methodologies, Dna Twopointo aims to support various applications in healthcare, agriculture, and environmental science, contributing to a deeper understanding of genetic information and its implications across multiple domains.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

37 Patents

#13 in Newark, CA

#2,198 in California

#9,288 in US

#18,329 in the World

Newark, CA, United States of America

Dna Twopointo Inc.

Forward Citations = 196

20 inventors:

Jeremy S Minshull (32 out of 126 patents)

Maggie Lee (17 out of 21 patents)

Sridhar Govindarajan (14 out of 39 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dna Twopointo Inc.. Retrieved from https://idiyas.com/company/dna-twopointo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…